Document is current

Article History

Received: 9 July 2018

Accepted: 8 October 2018

First Online: 19 October 2018

Compliance with ethical standards

:

: The study was performed according to the Helsinki Declaration and approved by the local Ethics Committee of the Medical University Frankfurt (Johann-Wolfgang Goethe University, Frankfurt am Main, Germany; Number: 442/13). This was a retrospective study evaluating perioperative data. Different questionnaires were utilized prospectively. A signed informed consent from the patients participating in the prospective collection of the questionnaires was mandatory.

: M. Grabbert, T. Hüsch, A. Kretschmer, R. Kirschner-Hermanns, R. Anding, A. Rose, A. Friedl, A. Obaje, A. Heidenreich, B. Brehmer, F. Queissert, J. Pfitzenmaier, J. Nyarangi-Dix, M. Kurosch, R. Olianas, R. Homberg, J. Schweiger, T. Hofmann, C. Wotzka and A. Haferkamp declare no potential conflict of interest. C. M. Naumann declares lectures, consultancy work, and participation in clinical trials for Coloplast. H. Loertzer declares lectures, consultancy work, and participation in clinical trials for Coloplast. R. Abdunnur declares consultancy work, lectures, and participation in clinical trials for AMS/Boston Scientific (Minnetonka, MN, USA) and Promedon (Cordoba, Argentina). T. Pottek declares consultancy work, lectures for Boston Scientific/AMS, Promedon, Zephyr, and Teleflex. W. Hübner declares consultancy work, lectures, and participation in clinical trials for Uromedica (Plymouth, MN, USA) and Promedon (Cordoba, Argentina). R. M. Bauer declares consultancy work, lectures, and participation in clinical trials for AMS/Boston Scientific (Minnetonka, MN, USA) and Promedon (Cordoba, Argentina).